1. Home
  2. JOB vs CING Comparison

JOB vs CING Comparison

Compare JOB & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEE Group Inc.

JOB

GEE Group Inc.

HOLD

Current Price

$0.19

Market Cap

22.5M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.21

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOB
CING
Founded
1893
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
26.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JOB
CING
Price
$0.19
$4.21
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
210.2K
122.1K
Earning Date
12-23-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$108,752,000.00
N/A
Revenue This Year
$43.94
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$3.20
52 Week High
$0.51
$6.01

Technical Indicators

Market Signals
Indicator
JOB
CING
Relative Strength Index (RSI) 50.86 61.63
Support Level $0.18 $3.75
Resistance Level $0.19 $4.02
Average True Range (ATR) 0.01 0.23
MACD 0.00 0.07
Stochastic Oscillator 96.63 76.01

Price Performance

Historical Comparison
JOB
CING

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: